nodes	percent_of_prediction	percent_of_DWPC	metapath
Cladribine—DCK—hematologic cancer	0.0893	0.646	CbGaD
Cladribine—Pentostatin—hematologic cancer	0.0866	0.296	CrCtD
Cladribine—Clofarabine—hematologic cancer	0.0772	0.263	CrCtD
Cladribine—Nelarabine—hematologic cancer	0.0726	0.248	CrCtD
Cladribine—Fludarabine—hematologic cancer	0.0567	0.193	CrCtD
Cladribine—SLC22A1—hematologic cancer	0.0288	0.208	CbGaD
Cladribine—Abacavir—Nelarabine—hematologic cancer	0.0208	0.104	CrCrCtD
Cladribine—ABCG2—hematologic cancer	0.0201	0.146	CbGaD
Cladribine—RRM2—Clofarabine—hematologic cancer	0.0166	0.0676	CbGbCtD
Cladribine—RRM1—Clofarabine—hematologic cancer	0.0166	0.0676	CbGbCtD
Cladribine—POLA1—Nelarabine—hematologic cancer	0.0157	0.0639	CbGbCtD
Cladribine—NR5A1—Daunorubicin—hematologic cancer	0.0146	0.0596	CbGbCtD
Cladribine—POLA1—Clofarabine—hematologic cancer	0.0143	0.0584	CbGbCtD
Cladribine—POLE—Cytarabine—hematologic cancer	0.0129	0.0526	CbGbCtD
Cladribine—RRM1—Fludarabine—hematologic cancer	0.0126	0.0512	CbGbCtD
Cladribine—RRM2—Hydroxyurea—hematologic cancer	0.0117	0.0476	CbGbCtD
Cladribine—RRM1—Hydroxyurea—hematologic cancer	0.0117	0.0476	CbGbCtD
Cladribine—POLA1—Fludarabine—hematologic cancer	0.0109	0.0443	CbGbCtD
Cladribine—SLC28A3—Fludarabine—hematologic cancer	0.0109	0.0443	CbGbCtD
Cladribine—DCK—Nelarabine—hematologic cancer	0.00966	0.0393	CbGbCtD
Cladribine—DCK—Clofarabine—hematologic cancer	0.00883	0.036	CbGbCtD
Cladribine—Idoxuridine—Pentostatin—hematologic cancer	0.00819	0.0409	CrCrCtD
Cladribine—Trifluridine—Pentostatin—hematologic cancer	0.00819	0.0409	CrCrCtD
Cladribine—Telbivudine—Pentostatin—hematologic cancer	0.00819	0.0409	CrCrCtD
Cladribine—POLE—Gemcitabine—hematologic cancer	0.00786	0.032	CbGbCtD
Cladribine—Floxuridine—Pentostatin—hematologic cancer	0.00745	0.0372	CrCrCtD
Cladribine—POLA1—Cytarabine—hematologic cancer	0.00742	0.0302	CbGbCtD
Cladribine—DCK—Fludarabine—hematologic cancer	0.00669	0.0273	CbGbCtD
Cladribine—SLC28A3—Mercaptopurine—hematologic cancer	0.00651	0.0265	CbGbCtD
Cladribine—NR5A1—Vinblastine—hematologic cancer	0.00623	0.0254	CbGbCtD
Cladribine—Regadenoson—Clofarabine—hematologic cancer	0.00528	0.0263	CrCrCtD
Cladribine—RRM2—Gemcitabine—hematologic cancer	0.00522	0.0213	CbGbCtD
Cladribine—RRM1—Gemcitabine—hematologic cancer	0.00522	0.0213	CbGbCtD
Cladribine—Clofarabine—Nelarabine—hematologic cancer	0.00496	0.0248	CrCrCtD
Cladribine—Regadenoson—Nelarabine—hematologic cancer	0.00496	0.0248	CrCrCtD
Cladribine—Fludarabine—Clofarabine—hematologic cancer	0.00495	0.0247	CrCrCtD
Cladribine—Vidarabine—Pentostatin—hematologic cancer	0.0047	0.0235	CrCrCtD
Cladribine—Adenosine—Pentostatin—hematologic cancer	0.0047	0.0235	CrCrCtD
Cladribine—Azacitidine—Pentostatin—hematologic cancer	0.0047	0.0235	CrCrCtD
Cladribine—Nelarabine—Clofarabine—hematologic cancer	0.00467	0.0233	CrCrCtD
Cladribine—Adenosine monophosphate—Clofarabine—hematologic cancer	0.00467	0.0233	CrCrCtD
Cladribine—Fludarabine—Nelarabine—hematologic cancer	0.00465	0.0232	CrCrCtD
Cladribine—DCK—Cytarabine—hematologic cancer	0.00457	0.0186	CbGbCtD
Cladribine—SLC28A3—Gemcitabine—hematologic cancer	0.00451	0.0184	CbGbCtD
Cladribine—POLA1—Gemcitabine—hematologic cancer	0.00451	0.0184	CbGbCtD
Cladribine—Decitabine—Pentostatin—hematologic cancer	0.00448	0.0224	CrCrCtD
Cladribine—Adenosine monophosphate—Nelarabine—hematologic cancer	0.00439	0.0219	CrCrCtD
Cladribine—NR5A1—ovarian follicle—hematologic cancer	0.00431	0.189	CbGeAlD
Cladribine—Vidarabine—Clofarabine—hematologic cancer	0.00419	0.0209	CrCrCtD
Cladribine—Azacitidine—Clofarabine—hematologic cancer	0.00419	0.0209	CrCrCtD
Cladribine—Adenosine—Clofarabine—hematologic cancer	0.00419	0.0209	CrCrCtD
Cladribine—Decitabine—Clofarabine—hematologic cancer	0.00399	0.0199	CrCrCtD
Cladribine—Adenosine—Nelarabine—hematologic cancer	0.00394	0.0197	CrCrCtD
Cladribine—Vidarabine—Nelarabine—hematologic cancer	0.00394	0.0197	CrCrCtD
Cladribine—Azacitidine—Nelarabine—hematologic cancer	0.00394	0.0197	CrCrCtD
Cladribine—Regadenoson—Fludarabine—hematologic cancer	0.00387	0.0193	CrCrCtD
Cladribine—Clofarabine—Fludarabine—hematologic cancer	0.00387	0.0193	CrCrCtD
Cladribine—Decitabine—Nelarabine—hematologic cancer	0.00376	0.0187	CrCrCtD
Cladribine—Regadenoson—Cytarabine—hematologic cancer	0.00366	0.0183	CrCrCtD
Cladribine—Clofarabine—Cytarabine—hematologic cancer	0.00366	0.0183	CrCrCtD
Cladribine—Fludarabine—Cytarabine—hematologic cancer	0.00343	0.0171	CrCrCtD
Cladribine—Nelarabine—Fludarabine—hematologic cancer	0.00342	0.0171	CrCrCtD
Cladribine—Adenosine monophosphate—Fludarabine—hematologic cancer	0.00342	0.0171	CrCrCtD
Cladribine—Adenosine monophosphate—Cytarabine—hematologic cancer	0.00323	0.0161	CrCrCtD
Cladribine—Nelarabine—Cytarabine—hematologic cancer	0.00323	0.0161	CrCrCtD
Cladribine—Vidarabine—Fludarabine—hematologic cancer	0.00308	0.0154	CrCrCtD
Cladribine—Adenosine—Fludarabine—hematologic cancer	0.00308	0.0154	CrCrCtD
Cladribine—Azacitidine—Fludarabine—hematologic cancer	0.00308	0.0154	CrCrCtD
Cladribine—Azacitidine—Gemcitabine—hematologic cancer	0.00291	0.0145	CrCrCtD
Cladribine—Vidarabine—Cytarabine—hematologic cancer	0.00291	0.0145	CrCrCtD
Cladribine—Adenosine—Cytarabine—hematologic cancer	0.00291	0.0145	CrCrCtD
Cladribine—Azacitidine—Cytarabine—hematologic cancer	0.00291	0.0145	CrCrCtD
Cladribine—DCK—Gemcitabine—hematologic cancer	0.00278	0.0113	CbGbCtD
Cladribine—Decitabine—Gemcitabine—hematologic cancer	0.00277	0.0138	CrCrCtD
Cladribine—Decitabine—Cytarabine—hematologic cancer	0.00277	0.0138	CrCrCtD
Cladribine—ABCG2—Clofarabine—hematologic cancer	0.00188	0.00766	CbGbCtD
Cladribine—SLC22A2—Daunorubicin—hematologic cancer	0.00149	0.00609	CbGbCtD
Cladribine—SLC22A2—Cytarabine—hematologic cancer	0.00132	0.00537	CbGbCtD
Cladribine—SLC22A1—Cytarabine—hematologic cancer	0.00115	0.00466	CbGbCtD
Cladribine—SLC22A2—Imatinib—hematologic cancer	0.00114	0.00466	CbGbCtD
Cladribine—ABCG2—Daunorubicin—hematologic cancer	0.0011	0.00449	CbGbCtD
Cladribine—SLC22A1—Imatinib—hematologic cancer	0.000994	0.00405	CbGbCtD
Cladribine—ABCG2—Teniposide—hematologic cancer	0.000959	0.0039	CbGbCtD
Cladribine—ABCG2—Imatinib—hematologic cancer	0.000845	0.00344	CbGbCtD
Cladribine—ABCG2—Nilotinib—hematologic cancer	0.000768	0.00313	CbGbCtD
Cladribine—ABCG2—Dasatinib—hematologic cancer	0.000679	0.00276	CbGbCtD
Cladribine—ABCG2—Mitoxantrone—hematologic cancer	0.00067	0.00273	CbGbCtD
Cladribine—POLE2—blood—hematologic cancer	0.00064	0.0281	CbGeAlD
Cladribine—SLC22A2—Vinblastine—hematologic cancer	0.000636	0.00259	CbGbCtD
Cladribine—POLE2—bone marrow—hematologic cancer	0.000619	0.0272	CbGeAlD
Cladribine—PNP—hematopoietic system—hematologic cancer	0.000611	0.0268	CbGeAlD
Cladribine—SLC22A2—Cisplatin—hematologic cancer	0.000583	0.00237	CbGbCtD
Cladribine—RRM2B—hematopoietic system—hematologic cancer	0.000567	0.0249	CbGeAlD
Cladribine—POLE2—lung—hematologic cancer	0.000561	0.0246	CbGeAlD
Cladribine—POLE3—hematopoietic system—hematologic cancer	0.000536	0.0235	CbGeAlD
Cladribine—POLE2—testis—hematologic cancer	0.00053	0.0233	CbGeAlD
Cladribine—ABCG2—Irinotecan—hematologic cancer	0.000528	0.00215	CbGbCtD
Cladribine—NR5A1—hematopoietic system—hematologic cancer	0.00052	0.0228	CbGeAlD
Cladribine—ABCG2—Vincristine—hematologic cancer	0.000461	0.00188	CbGbCtD
Cladribine—ABCG2—Cisplatin—hematologic cancer	0.00043	0.00175	CbGbCtD
Cladribine—ABCG2—Etoposide—hematologic cancer	0.000423	0.00172	CbGbCtD
Cladribine—POLE—hematopoietic system—hematologic cancer	0.000409	0.018	CbGeAlD
Cladribine—POLE3—gonad—hematologic cancer	0.000408	0.0179	CbGeAlD
Cladribine—PNP—blood—hematologic cancer	0.000405	0.0178	CbGeAlD
Cladribine—NR5A1—gonad—hematologic cancer	0.000395	0.0174	CbGeAlD
Cladribine—PNP—bone marrow—hematologic cancer	0.000392	0.0172	CbGeAlD
Cladribine—POLE2—lymph node—hematologic cancer	0.000384	0.0169	CbGeAlD
Cladribine—RRM2B—blood—hematologic cancer	0.000376	0.0165	CbGeAlD
Cladribine—RRM2B—bone marrow—hematologic cancer	0.000364	0.016	CbGeAlD
Cladribine—POLE3—blood—hematologic cancer	0.000355	0.0156	CbGeAlD
Cladribine—PNP—lung—hematologic cancer	0.000355	0.0156	CbGeAlD
Cladribine—POLA1—hematopoietic system—hematologic cancer	0.000353	0.0155	CbGeAlD
Cladribine—ABCG2—Dexamethasone—hematologic cancer	0.000348	0.00142	CbGbCtD
Cladribine—POLE3—bone marrow—hematologic cancer	0.000344	0.0151	CbGeAlD
Cladribine—RRM2—hematopoietic system—hematologic cancer	0.000337	0.0148	CbGeAlD
Cladribine—RRM2B—lung—hematologic cancer	0.00033	0.0145	CbGeAlD
Cladribine—SLC28A3—bone marrow—hematologic cancer	0.000322	0.0141	CbGeAlD
Cladribine—POLE3—lung—hematologic cancer	0.000311	0.0137	CbGeAlD
Cladribine—POLE—gonad—hematologic cancer	0.000311	0.0137	CbGeAlD
Cladribine—RRM2B—testis—hematologic cancer	0.000311	0.0137	CbGeAlD
Cladribine—POLE3—testis—hematologic cancer	0.000294	0.0129	CbGeAlD
Cladribine—SLC28A3—lung—hematologic cancer	0.000292	0.0128	CbGeAlD
Cladribine—ABCG2—Doxorubicin—hematologic cancer	0.000288	0.00117	CbGbCtD
Cladribine—NR5A1—testis—hematologic cancer	0.000285	0.0125	CbGeAlD
Cladribine—RRM1—hematopoietic system—hematologic cancer	0.00028	0.0123	CbGeAlD
Cladribine—ABCG2—Methotrexate—hematologic cancer	0.000279	0.00114	CbGbCtD
Cladribine—POLE—blood—hematologic cancer	0.000271	0.0119	CbGeAlD
Cladribine—POLE—bone marrow—hematologic cancer	0.000262	0.0115	CbGeAlD
Cladribine—RRM2—gonad—hematologic cancer	0.000256	0.0112	CbGeAlD
Cladribine—POLE—lung—hematologic cancer	0.000238	0.0104	CbGeAlD
Cladribine—POLA1—blood—hematologic cancer	0.000234	0.0103	CbGeAlD
Cladribine—POLA1—bone marrow—hematologic cancer	0.000226	0.00993	CbGeAlD
Cladribine—RRM2B—lymph node—hematologic cancer	0.000225	0.0099	CbGeAlD
Cladribine—POLE—testis—hematologic cancer	0.000224	0.00985	CbGeAlD
Cladribine—RRM2—blood—hematologic cancer	0.000223	0.0098	CbGeAlD
Cladribine—DCK—hematopoietic system—hematologic cancer	0.000217	0.00955	CbGeAlD
Cladribine—RRM2—bone marrow—hematologic cancer	0.000216	0.00948	CbGeAlD
Cladribine—POLE3—lymph node—hematologic cancer	0.000213	0.00935	CbGeAlD
Cladribine—RRM1—gonad—hematologic cancer	0.000213	0.00934	CbGeAlD
Cladribine—POLA1—lung—hematologic cancer	0.000205	0.00899	CbGeAlD
Cladribine—RRM2—lung—hematologic cancer	0.000196	0.00859	CbGeAlD
Cladribine—POLA1—testis—hematologic cancer	0.000193	0.00849	CbGeAlD
Cladribine—RRM1—blood—hematologic cancer	0.000185	0.00814	CbGeAlD
Cladribine—Azacitidine—DNMT3A—hematologic cancer	0.000185	0.134	CrCbGaD
Cladribine—RRM2—testis—hematologic cancer	0.000185	0.00811	CbGeAlD
Cladribine—Decitabine—DNMT3A—hematologic cancer	0.000181	0.13	CrCbGaD
Cladribine—RRM1—bone marrow—hematologic cancer	0.000179	0.00788	CbGeAlD
Cladribine—DCK—gonad—hematologic cancer	0.000165	0.00726	CbGeAlD
Cladribine—Azacitidine—CDA—hematologic cancer	0.000165	0.119	CrCbGaD
Cladribine—RRM1—lung—hematologic cancer	0.000163	0.00714	CbGeAlD
Cladribine—POLE—lymph node—hematologic cancer	0.000163	0.00714	CbGeAlD
Cladribine—RRM1—testis—hematologic cancer	0.000153	0.00674	CbGeAlD
Cladribine—DCK—blood—hematologic cancer	0.000144	0.00632	CbGeAlD
Cladribine—Decitabine—DCK—hematologic cancer	0.000142	0.102	CrCbGaD
Cladribine—POLA1—lymph node—hematologic cancer	0.00014	0.00615	CbGeAlD
Cladribine—DCK—bone marrow—hematologic cancer	0.000139	0.00612	CbGeAlD
Cladribine—Nelarabine—DCK—hematologic cancer	0.000137	0.0986	CrCbGaD
Cladribine—Abacavir—UGT1A1—hematologic cancer	0.000134	0.0966	CrCbGaD
Cladribine—RRM2—lymph node—hematologic cancer	0.000134	0.00588	CbGeAlD
Cladribine—Clofarabine—DCK—hematologic cancer	0.000133	0.0959	CrCbGaD
Cladribine—Fludarabine—DCK—hematologic cancer	0.000129	0.0929	CrCbGaD
Cladribine—DCK—lung—hematologic cancer	0.000126	0.00554	CbGeAlD
Cladribine—SLC22A1—blood—hematologic cancer	0.000123	0.00539	CbGeAlD
Cladribine—DCK—testis—hematologic cancer	0.000119	0.00523	CbGeAlD
Cladribine—RRM1—lymph node—hematologic cancer	0.000111	0.00488	CbGeAlD
Cladribine—DCK—lymph node—hematologic cancer	8.64e-05	0.00379	CbGeAlD
Cladribine—Adenosine monophosphate—CREB1—hematologic cancer	8.51e-05	0.0614	CrCbGaD
Cladribine—ABCG2—blood—hematologic cancer	8.04e-05	0.00353	CbGeAlD
Cladribine—ABCG2—bone marrow—hematologic cancer	7.78e-05	0.00341	CbGeAlD
Cladribine—ABCG2—lung—hematologic cancer	7.04e-05	0.00309	CbGeAlD
Cladribine—ABCG2—testis—hematologic cancer	6.65e-05	0.00292	CbGeAlD
Cladribine—PNP—Ponatinib—Nilotinib—hematologic cancer	6.21e-05	0.0544	CbGdCrCtD
Cladribine—POLE2—Topotecan—Irinotecan—hematologic cancer	5.78e-05	0.0506	CbGdCrCtD
Cladribine—ABCG2—lymph node—hematologic cancer	4.82e-05	0.00212	CbGeAlD
Cladribine—PNP—Ponatinib—Imatinib—hematologic cancer	4.71e-05	0.0412	CbGdCrCtD
Cladribine—POLE2—Floxuridine—Pentostatin—hematologic cancer	3.98e-05	0.0349	CbGdCrCtD
Cladribine—POLE2—Idarubicin—Daunorubicin—hematologic cancer	3.91e-05	0.0342	CbGdCrCtD
Cladribine—POLE2—Doxorubicin—Daunorubicin—hematologic cancer	3.91e-05	0.0342	CbGdCrCtD
Cladribine—POLE2—Epirubicin—Daunorubicin—hematologic cancer	3.91e-05	0.0342	CbGdCrCtD
Cladribine—Adenosine monophosphate—SRC—hematologic cancer	3.44e-05	0.0248	CrCbGaD
Cladribine—POLE2—Menadione—Thalidomide—hematologic cancer	3.32e-05	0.0291	CbGdCrCtD
Cladribine—Adenosine monophosphate—PDE4B—hematologic cancer	3.08e-05	0.0222	CrCbGaD
Cladribine—Clofarabine—ABCG2—hematologic cancer	3e-05	0.0216	CrCbGaD
Cladribine—POLE2—Doxorubicin—Idarubicin—hematologic cancer	2.96e-05	0.0259	CbGdCrCtD
Cladribine—POLE2—Epirubicin—Idarubicin—hematologic cancer	2.96e-05	0.0259	CbGdCrCtD
Cladribine—POLE2—Daunorubicin—Idarubicin—hematologic cancer	2.96e-05	0.0259	CbGdCrCtD
Cladribine—POLE2—Teniposide—Etoposide—hematologic cancer	2.61e-05	0.0228	CbGdCrCtD
Cladribine—DCK—Topotecan—Irinotecan—hematologic cancer	2.61e-05	0.0228	CbGdCrCtD
Cladribine—POLA1—Vinblastine—Vinorelbine—hematologic cancer	2.45e-05	0.0215	CbGdCrCtD
Cladribine—PNP—Daunorubicin—Idarubicin—hematologic cancer	2.28e-05	0.02	CbGdCrCtD
Cladribine—RRM1—Azacitidine—Pentostatin—hematologic cancer	2.15e-05	0.0188	CbGdCrCtD
Cladribine—RRM2—Vinorelbine—Vincristine—hematologic cancer	2.07e-05	0.0181	CbGdCrCtD
Cladribine—RRM2—Vinorelbine—Vinblastine—hematologic cancer	2.07e-05	0.0181	CbGdCrCtD
Cladribine—POLA1—Vinblastine—Vincristine—hematologic cancer	1.96e-05	0.0172	CbGdCrCtD
Cladribine—RRM1—Azacitidine—Clofarabine—hematologic cancer	1.92e-05	0.0168	CbGdCrCtD
Cladribine—RRM1—Azacitidine—Nelarabine—hematologic cancer	1.8e-05	0.0158	CbGdCrCtD
Cladribine—DCK—Epirubicin—Daunorubicin—hematologic cancer	1.76e-05	0.0154	CbGdCrCtD
Cladribine—DCK—Doxorubicin—Daunorubicin—hematologic cancer	1.76e-05	0.0154	CbGdCrCtD
Cladribine—POLE2—Azacitidine—Pentostatin—hematologic cancer	1.7e-05	0.0149	CbGdCrCtD
Cladribine—POLE2—Azacitidine—Clofarabine—hematologic cancer	1.52e-05	0.0133	CbGdCrCtD
Cladribine—DCK—Menadione—Thalidomide—hematologic cancer	1.5e-05	0.0131	CbGdCrCtD
Cladribine—POLE2—Azacitidine—Nelarabine—hematologic cancer	1.43e-05	0.0125	CbGdCrCtD
Cladribine—RRM1—Azacitidine—Fludarabine—hematologic cancer	1.41e-05	0.0123	CbGdCrCtD
Cladribine—POLE2—Idarubicin—Epirubicin—hematologic cancer	1.36e-05	0.0119	CbGdCrCtD
Cladribine—POLE2—Doxorubicin—Epirubicin—hematologic cancer	1.36e-05	0.0119	CbGdCrCtD
Cladribine—POLE2—Daunorubicin—Epirubicin—hematologic cancer	1.36e-05	0.0119	CbGdCrCtD
Cladribine—RRM2—Azacitidine—Pentostatin—hematologic cancer	1.35e-05	0.0118	CbGdCrCtD
Cladribine—DCK—Epirubicin—Idarubicin—hematologic cancer	1.33e-05	0.0117	CbGdCrCtD
Cladribine—DCK—Doxorubicin—Idarubicin—hematologic cancer	1.33e-05	0.0117	CbGdCrCtD
Cladribine—RRM1—Azacitidine—Gemcitabine—hematologic cancer	1.33e-05	0.0116	CbGdCrCtD
Cladribine—RRM1—Azacitidine—Cytarabine—hematologic cancer	1.33e-05	0.0116	CbGdCrCtD
Cladribine—POLE2—Idarubicin—Doxorubicin—hematologic cancer	1.26e-05	0.011	CbGdCrCtD
Cladribine—POLE2—Epirubicin—Doxorubicin—hematologic cancer	1.26e-05	0.011	CbGdCrCtD
Cladribine—POLE2—Daunorubicin—Doxorubicin—hematologic cancer	1.26e-05	0.011	CbGdCrCtD
Cladribine—RRM2—Azacitidine—Clofarabine—hematologic cancer	1.2e-05	0.0105	CbGdCrCtD
Cladribine—RRM2—Azacitidine—Nelarabine—hematologic cancer	1.13e-05	0.00991	CbGdCrCtD
Cladribine—POLE2—Azacitidine—Fludarabine—hematologic cancer	1.11e-05	0.00974	CbGdCrCtD
Cladribine—POLE2—Azacitidine—Cytarabine—hematologic cancer	1.05e-05	0.0092	CbGdCrCtD
Cladribine—POLE2—Azacitidine—Gemcitabine—hematologic cancer	1.05e-05	0.0092	CbGdCrCtD
Cladribine—PNP—Daunorubicin—Epirubicin—hematologic cancer	1.05e-05	0.00918	CbGdCrCtD
Cladribine—PNP—Daunorubicin—Doxorubicin—hematologic cancer	9.71e-06	0.00849	CbGdCrCtD
Cladribine—RRM2—Azacitidine—Fludarabine—hematologic cancer	8.84e-06	0.00774	CbGdCrCtD
Cladribine—RRM2—Azacitidine—Cytarabine—hematologic cancer	8.35e-06	0.00731	CbGdCrCtD
Cladribine—RRM2—Azacitidine—Gemcitabine—hematologic cancer	8.35e-06	0.00731	CbGdCrCtD
Cladribine—DCK—Doxorubicin—Epirubicin—hematologic cancer	6.13e-06	0.00536	CbGdCrCtD
Cladribine—DCK—Epirubicin—Doxorubicin—hematologic cancer	5.67e-06	0.00496	CbGdCrCtD
Cladribine—PNP—Clobetasol propionate—Dexamethasone—hematologic cancer	4.99e-06	0.00437	CbGdCrCtD
Cladribine—PNP—Clobetasol propionate—Betamethasone—hematologic cancer	4.99e-06	0.00437	CbGdCrCtD
Cladribine—PNP—Flunisolide—Dexamethasone—hematologic cancer	4.93e-06	0.00431	CbGdCrCtD
Cladribine—PNP—Flunisolide—Betamethasone—hematologic cancer	4.93e-06	0.00431	CbGdCrCtD
Cladribine—PNP—Clobetasol propionate—Triamcinolone—hematologic cancer	4.88e-06	0.00427	CbGdCrCtD
Cladribine—PNP—Flunisolide—Triamcinolone—hematologic cancer	4.82e-06	0.00421	CbGdCrCtD
Cladribine—PNP—Fluticasone Propionate—Betamethasone—hematologic cancer	4.76e-06	0.00416	CbGdCrCtD
Cladribine—PNP—Fluticasone Propionate—Dexamethasone—hematologic cancer	4.76e-06	0.00416	CbGdCrCtD
Cladribine—PNP—Fluticasone Propionate—Triamcinolone—hematologic cancer	4.65e-06	0.00407	CbGdCrCtD
Cladribine—PNP—Clobetasol propionate—Prednisone—hematologic cancer	4.63e-06	0.00405	CbGdCrCtD
Cladribine—PNP—Flunisolide—Prednisone—hematologic cancer	4.57e-06	0.004	CbGdCrCtD
Cladribine—PNP—Clobetasol propionate—Prednisolone—hematologic cancer	4.52e-06	0.00396	CbGdCrCtD
Cladribine—PNP—Fluocinolone Acetonide—Betamethasone—hematologic cancer	4.48e-06	0.00392	CbGdCrCtD
Cladribine—PNP—Fluocinolone Acetonide—Dexamethasone—hematologic cancer	4.48e-06	0.00392	CbGdCrCtD
Cladribine—PNP—Flunisolide—Prednisolone—hematologic cancer	4.46e-06	0.0039	CbGdCrCtD
Cladribine—PNP—Fluocinolone Acetonide—Triamcinolone—hematologic cancer	4.38e-06	0.00383	CbGdCrCtD
Cladribine—PNP—Fluocinolone Acetonide—Prednisolone—hematologic cancer	4.06e-06	0.00355	CbGdCrCtD
Cladribine—Angiopathy—Epirubicin—hematologic cancer	3.84e-06	6.05e-05	CcSEcCtD
Cladribine—Urethral disorder—Doxorubicin—hematologic cancer	3.84e-06	6.05e-05	CcSEcCtD
Cladribine—Decreased appetite—Dexamethasone—hematologic cancer	3.84e-06	6.05e-05	CcSEcCtD
Cladribine—Decreased appetite—Betamethasone—hematologic cancer	3.84e-06	6.05e-05	CcSEcCtD
Cladribine—Nausea—Irinotecan—hematologic cancer	3.83e-06	6.04e-05	CcSEcCtD
Cladribine—Nausea—Mitoxantrone—hematologic cancer	3.83e-06	6.04e-05	CcSEcCtD
Cladribine—Immune system disorder—Epirubicin—hematologic cancer	3.83e-06	6.03e-05	CcSEcCtD
Cladribine—Infection—Prednisone—hematologic cancer	3.82e-06	6.02e-05	CcSEcCtD
Cladribine—Mediastinal disorder—Epirubicin—hematologic cancer	3.82e-06	6.01e-05	CcSEcCtD
Cladribine—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.82e-06	6.01e-05	CcSEcCtD
Cladribine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.82e-06	6.01e-05	CcSEcCtD
Cladribine—Back pain—Methotrexate—hematologic cancer	3.81e-06	6e-05	CcSEcCtD
Cladribine—Fatigue—Betamethasone—hematologic cancer	3.81e-06	6e-05	CcSEcCtD
Cladribine—Fatigue—Dexamethasone—hematologic cancer	3.81e-06	6e-05	CcSEcCtD
Cladribine—Chills—Epirubicin—hematologic cancer	3.8e-06	5.99e-05	CcSEcCtD
Cladribine—Pruritus—Etoposide—hematologic cancer	3.8e-06	5.98e-05	CcSEcCtD
Cladribine—Arrhythmia—Epirubicin—hematologic cancer	3.79e-06	5.96e-05	CcSEcCtD
Cladribine—Pain—Betamethasone—hematologic cancer	3.78e-06	5.95e-05	CcSEcCtD
Cladribine—Pain—Dexamethasone—hematologic cancer	3.78e-06	5.95e-05	CcSEcCtD
Cladribine—Nervous system disorder—Prednisone—hematologic cancer	3.77e-06	5.94e-05	CcSEcCtD
Cladribine—Tachycardia—Prednisone—hematologic cancer	3.76e-06	5.92e-05	CcSEcCtD
Cladribine—Alopecia—Epirubicin—hematologic cancer	3.74e-06	5.9e-05	CcSEcCtD
Cladribine—Skin disorder—Prednisone—hematologic cancer	3.74e-06	5.89e-05	CcSEcCtD
Cladribine—Nausea—Gemcitabine—hematologic cancer	3.74e-06	5.88e-05	CcSEcCtD
Cladribine—Vomiting—Cisplatin—hematologic cancer	3.73e-06	5.87e-05	CcSEcCtD
Cladribine—Hyperhidrosis—Prednisone—hematologic cancer	3.72e-06	5.86e-05	CcSEcCtD
Cladribine—Mental disorder—Epirubicin—hematologic cancer	3.71e-06	5.85e-05	CcSEcCtD
Cladribine—Erythema multiforme—Doxorubicin—hematologic cancer	3.71e-06	5.84e-05	CcSEcCtD
Cladribine—Rash—Cisplatin—hematologic cancer	3.7e-06	5.82e-05	CcSEcCtD
Cladribine—Dermatitis—Cisplatin—hematologic cancer	3.69e-06	5.82e-05	CcSEcCtD
Cladribine—Erythema—Epirubicin—hematologic cancer	3.69e-06	5.81e-05	CcSEcCtD
Cladribine—Malnutrition—Epirubicin—hematologic cancer	3.69e-06	5.81e-05	CcSEcCtD
Cladribine—Diarrhoea—Etoposide—hematologic cancer	3.67e-06	5.79e-05	CcSEcCtD
Cladribine—Anorexia—Prednisone—hematologic cancer	3.67e-06	5.78e-05	CcSEcCtD
Cladribine—Eye disorder—Doxorubicin—hematologic cancer	3.66e-06	5.77e-05	CcSEcCtD
Cladribine—Ill-defined disorder—Methotrexate—hematologic cancer	3.66e-06	5.76e-05	CcSEcCtD
Cladribine—Anaemia—Methotrexate—hematologic cancer	3.64e-06	5.74e-05	CcSEcCtD
Cladribine—Feeling abnormal—Dexamethasone—hematologic cancer	3.64e-06	5.74e-05	CcSEcCtD
Cladribine—Feeling abnormal—Betamethasone—hematologic cancer	3.64e-06	5.74e-05	CcSEcCtD
Cladribine—Cardiac disorder—Doxorubicin—hematologic cancer	3.64e-06	5.73e-05	CcSEcCtD
Cladribine—Flatulence—Epirubicin—hematologic cancer	3.63e-06	5.72e-05	CcSEcCtD
Cladribine—Gastrointestinal pain—Betamethasone—hematologic cancer	3.61e-06	5.69e-05	CcSEcCtD
Cladribine—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.61e-06	5.69e-05	CcSEcCtD
Cladribine—Hypersensitivity—Triamcinolone—hematologic cancer	3.59e-06	5.65e-05	CcSEcCtD
Cladribine—Back pain—Epirubicin—hematologic cancer	3.57e-06	5.62e-05	CcSEcCtD
Cladribine—Angiopathy—Doxorubicin—hematologic cancer	3.56e-06	5.6e-05	CcSEcCtD
Cladribine—Malaise—Methotrexate—hematologic cancer	3.55e-06	5.6e-05	CcSEcCtD
Cladribine—Dizziness—Etoposide—hematologic cancer	3.55e-06	5.59e-05	CcSEcCtD
Cladribine—Immune system disorder—Doxorubicin—hematologic cancer	3.54e-06	5.58e-05	CcSEcCtD
Cladribine—Mediastinal disorder—Doxorubicin—hematologic cancer	3.53e-06	5.56e-05	CcSEcCtD
Cladribine—Chills—Doxorubicin—hematologic cancer	3.52e-06	5.54e-05	CcSEcCtD
Cladribine—Urticaria—Betamethasone—hematologic cancer	3.51e-06	5.53e-05	CcSEcCtD
Cladribine—Urticaria—Dexamethasone—hematologic cancer	3.51e-06	5.53e-05	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.51e-06	5.52e-05	CcSEcCtD
Cladribine—PNP—Danazol—Prednisone—hematologic cancer	3.5e-06	0.00307	CbGdCrCtD
Cladribine—Dizziness—Prednisolone—hematologic cancer	3.5e-06	5.52e-05	CcSEcCtD
Cladribine—Arrhythmia—Doxorubicin—hematologic cancer	3.5e-06	5.52e-05	CcSEcCtD
Cladribine—Asthenia—Triamcinolone—hematologic cancer	3.49e-06	5.5e-05	CcSEcCtD
Cladribine—Body temperature increased—Betamethasone—hematologic cancer	3.49e-06	5.5e-05	CcSEcCtD
Cladribine—Body temperature increased—Dexamethasone—hematologic cancer	3.49e-06	5.5e-05	CcSEcCtD
Cladribine—Abdominal pain—Dexamethasone—hematologic cancer	3.49e-06	5.5e-05	CcSEcCtD
Cladribine—Abdominal pain—Betamethasone—hematologic cancer	3.49e-06	5.5e-05	CcSEcCtD
Cladribine—Nausea—Cisplatin—hematologic cancer	3.48e-06	5.48e-05	CcSEcCtD
Cladribine—Insomnia—Prednisone—hematologic cancer	3.48e-06	5.48e-05	CcSEcCtD
Cladribine—Alopecia—Doxorubicin—hematologic cancer	3.46e-06	5.46e-05	CcSEcCtD
Cladribine—Paraesthesia—Prednisone—hematologic cancer	3.46e-06	5.44e-05	CcSEcCtD
Cladribine—Pruritus—Triamcinolone—hematologic cancer	3.45e-06	5.43e-05	CcSEcCtD
Cladribine—Cough—Methotrexate—hematologic cancer	3.44e-06	5.42e-05	CcSEcCtD
Cladribine—Mental disorder—Doxorubicin—hematologic cancer	3.43e-06	5.41e-05	CcSEcCtD
Cladribine—Ill-defined disorder—Epirubicin—hematologic cancer	3.42e-06	5.39e-05	CcSEcCtD
Cladribine—Vomiting—Etoposide—hematologic cancer	3.41e-06	5.38e-05	CcSEcCtD
Cladribine—Malnutrition—Doxorubicin—hematologic cancer	3.41e-06	5.37e-05	CcSEcCtD
Cladribine—Erythema—Doxorubicin—hematologic cancer	3.41e-06	5.37e-05	CcSEcCtD
Cladribine—Anaemia—Epirubicin—hematologic cancer	3.41e-06	5.37e-05	CcSEcCtD
Cladribine—Rash—Etoposide—hematologic cancer	3.39e-06	5.33e-05	CcSEcCtD
Cladribine—Dermatitis—Etoposide—hematologic cancer	3.38e-06	5.33e-05	CcSEcCtD
Cladribine—Headache—Etoposide—hematologic cancer	3.36e-06	5.3e-05	CcSEcCtD
Cladribine—Flatulence—Doxorubicin—hematologic cancer	3.36e-06	5.3e-05	CcSEcCtD
Cladribine—Arthralgia—Methotrexate—hematologic cancer	3.36e-06	5.28e-05	CcSEcCtD
Cladribine—Chest pain—Methotrexate—hematologic cancer	3.36e-06	5.28e-05	CcSEcCtD
Cladribine—Myalgia—Methotrexate—hematologic cancer	3.36e-06	5.28e-05	CcSEcCtD
Cladribine—Decreased appetite—Prednisone—hematologic cancer	3.35e-06	5.27e-05	CcSEcCtD
Cladribine—Rash—Prednisolone—hematologic cancer	3.34e-06	5.26e-05	CcSEcCtD
Cladribine—Dermatitis—Prednisolone—hematologic cancer	3.34e-06	5.25e-05	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.33e-06	5.25e-05	CcSEcCtD
Cladribine—Malaise—Epirubicin—hematologic cancer	3.33e-06	5.24e-05	CcSEcCtD
Cladribine—Fatigue—Prednisone—hematologic cancer	3.32e-06	5.23e-05	CcSEcCtD
Cladribine—Headache—Prednisolone—hematologic cancer	3.32e-06	5.23e-05	CcSEcCtD
Cladribine—Discomfort—Methotrexate—hematologic cancer	3.32e-06	5.22e-05	CcSEcCtD
Cladribine—Back pain—Doxorubicin—hematologic cancer	3.3e-06	5.2e-05	CcSEcCtD
Cladribine—Constipation—Prednisone—hematologic cancer	3.29e-06	5.18e-05	CcSEcCtD
Cladribine—Confusional state—Methotrexate—hematologic cancer	3.24e-06	5.11e-05	CcSEcCtD
Cladribine—Dizziness—Triamcinolone—hematologic cancer	3.22e-06	5.07e-05	CcSEcCtD
Cladribine—Cough—Epirubicin—hematologic cancer	3.22e-06	5.07e-05	CcSEcCtD
Cladribine—Infection—Methotrexate—hematologic cancer	3.2e-06	5.03e-05	CcSEcCtD
Cladribine—Nausea—Etoposide—hematologic cancer	3.19e-06	5.02e-05	CcSEcCtD
Cladribine—Feeling abnormal—Prednisone—hematologic cancer	3.17e-06	5e-05	CcSEcCtD
Cladribine—Asthenia—Betamethasone—hematologic cancer	3.17e-06	4.99e-05	CcSEcCtD
Cladribine—Asthenia—Dexamethasone—hematologic cancer	3.17e-06	4.99e-05	CcSEcCtD
Cladribine—Ill-defined disorder—Doxorubicin—hematologic cancer	3.17e-06	4.99e-05	CcSEcCtD
Cladribine—Nervous system disorder—Methotrexate—hematologic cancer	3.15e-06	4.97e-05	CcSEcCtD
Cladribine—Anaemia—Doxorubicin—hematologic cancer	3.15e-06	4.97e-05	CcSEcCtD
Cladribine—Thrombocytopenia—Methotrexate—hematologic cancer	3.15e-06	4.96e-05	CcSEcCtD
Cladribine—Gastrointestinal pain—Prednisone—hematologic cancer	3.15e-06	4.96e-05	CcSEcCtD
Cladribine—Nausea—Prednisolone—hematologic cancer	3.15e-06	4.95e-05	CcSEcCtD
Cladribine—Chest pain—Epirubicin—hematologic cancer	3.14e-06	4.95e-05	CcSEcCtD
Cladribine—Arthralgia—Epirubicin—hematologic cancer	3.14e-06	4.95e-05	CcSEcCtD
Cladribine—Myalgia—Epirubicin—hematologic cancer	3.14e-06	4.95e-05	CcSEcCtD
Cladribine—Anxiety—Epirubicin—hematologic cancer	3.13e-06	4.93e-05	CcSEcCtD
Cladribine—Pruritus—Betamethasone—hematologic cancer	3.13e-06	4.92e-05	CcSEcCtD
Cladribine—Pruritus—Dexamethasone—hematologic cancer	3.13e-06	4.92e-05	CcSEcCtD
Cladribine—Skin disorder—Methotrexate—hematologic cancer	3.12e-06	4.92e-05	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.12e-06	4.91e-05	CcSEcCtD
Cladribine—Hyperhidrosis—Methotrexate—hematologic cancer	3.11e-06	4.9e-05	CcSEcCtD
Cladribine—Discomfort—Epirubicin—hematologic cancer	3.1e-06	4.89e-05	CcSEcCtD
Cladribine—Vomiting—Triamcinolone—hematologic cancer	3.1e-06	4.88e-05	CcSEcCtD
Cladribine—Malaise—Doxorubicin—hematologic cancer	3.08e-06	4.85e-05	CcSEcCtD
Cladribine—Rash—Triamcinolone—hematologic cancer	3.07e-06	4.84e-05	CcSEcCtD
Cladribine—Dermatitis—Triamcinolone—hematologic cancer	3.07e-06	4.83e-05	CcSEcCtD
Cladribine—Anorexia—Methotrexate—hematologic cancer	3.07e-06	4.83e-05	CcSEcCtD
Cladribine—Urticaria—Prednisone—hematologic cancer	3.06e-06	4.82e-05	CcSEcCtD
Cladribine—Headache—Triamcinolone—hematologic cancer	3.05e-06	4.81e-05	CcSEcCtD
Cladribine—Body temperature increased—Prednisone—hematologic cancer	3.04e-06	4.79e-05	CcSEcCtD
Cladribine—Abdominal pain—Prednisone—hematologic cancer	3.04e-06	4.79e-05	CcSEcCtD
Cladribine—Confusional state—Epirubicin—hematologic cancer	3.04e-06	4.78e-05	CcSEcCtD
Cladribine—Diarrhoea—Betamethasone—hematologic cancer	3.02e-06	4.76e-05	CcSEcCtD
Cladribine—Diarrhoea—Dexamethasone—hematologic cancer	3.02e-06	4.76e-05	CcSEcCtD
Cladribine—Oedema—Epirubicin—hematologic cancer	3.01e-06	4.74e-05	CcSEcCtD
Cladribine—Hypotension—Methotrexate—hematologic cancer	3.01e-06	4.73e-05	CcSEcCtD
Cladribine—Infection—Epirubicin—hematologic cancer	2.99e-06	4.71e-05	CcSEcCtD
Cladribine—Cough—Doxorubicin—hematologic cancer	2.98e-06	4.69e-05	CcSEcCtD
Cladribine—Nervous system disorder—Epirubicin—hematologic cancer	2.95e-06	4.65e-05	CcSEcCtD
Cladribine—Thrombocytopenia—Epirubicin—hematologic cancer	2.95e-06	4.64e-05	CcSEcCtD
Cladribine—Tachycardia—Epirubicin—hematologic cancer	2.94e-06	4.63e-05	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.93e-06	4.62e-05	CcSEcCtD
Cladribine—Skin disorder—Epirubicin—hematologic cancer	2.92e-06	4.6e-05	CcSEcCtD
Cladribine—Dizziness—Betamethasone—hematologic cancer	2.92e-06	4.6e-05	CcSEcCtD
Cladribine—Dizziness—Dexamethasone—hematologic cancer	2.92e-06	4.6e-05	CcSEcCtD
Cladribine—Hyperhidrosis—Epirubicin—hematologic cancer	2.91e-06	4.58e-05	CcSEcCtD
Cladribine—Insomnia—Methotrexate—hematologic cancer	2.91e-06	4.58e-05	CcSEcCtD
Cladribine—Chest pain—Doxorubicin—hematologic cancer	2.91e-06	4.58e-05	CcSEcCtD
Cladribine—Arthralgia—Doxorubicin—hematologic cancer	2.91e-06	4.58e-05	CcSEcCtD
Cladribine—Myalgia—Doxorubicin—hematologic cancer	2.91e-06	4.58e-05	CcSEcCtD
Cladribine—Anxiety—Doxorubicin—hematologic cancer	2.9e-06	4.56e-05	CcSEcCtD
Cladribine—Nausea—Triamcinolone—hematologic cancer	2.89e-06	4.56e-05	CcSEcCtD
Cladribine—Paraesthesia—Methotrexate—hematologic cancer	2.89e-06	4.55e-05	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.89e-06	4.54e-05	CcSEcCtD
Cladribine—Discomfort—Doxorubicin—hematologic cancer	2.87e-06	4.52e-05	CcSEcCtD
Cladribine—Anorexia—Epirubicin—hematologic cancer	2.87e-06	4.52e-05	CcSEcCtD
Cladribine—Dyspnoea—Methotrexate—hematologic cancer	2.87e-06	4.52e-05	CcSEcCtD
Cladribine—Somnolence—Methotrexate—hematologic cancer	2.86e-06	4.5e-05	CcSEcCtD
Cladribine—Hypersensitivity—Prednisone—hematologic cancer	2.84e-06	4.47e-05	CcSEcCtD
Cladribine—Hypotension—Epirubicin—hematologic cancer	2.81e-06	4.43e-05	CcSEcCtD
Cladribine—Vomiting—Dexamethasone—hematologic cancer	2.81e-06	4.43e-05	CcSEcCtD
Cladribine—Vomiting—Betamethasone—hematologic cancer	2.81e-06	4.43e-05	CcSEcCtD
Cladribine—Confusional state—Doxorubicin—hematologic cancer	2.81e-06	4.42e-05	CcSEcCtD
Cladribine—Decreased appetite—Methotrexate—hematologic cancer	2.8e-06	4.4e-05	CcSEcCtD
Cladribine—Rash—Dexamethasone—hematologic cancer	2.79e-06	4.39e-05	CcSEcCtD
Cladribine—Rash—Betamethasone—hematologic cancer	2.79e-06	4.39e-05	CcSEcCtD
Cladribine—Oedema—Doxorubicin—hematologic cancer	2.79e-06	4.39e-05	CcSEcCtD
Cladribine—Dermatitis—Dexamethasone—hematologic cancer	2.78e-06	4.38e-05	CcSEcCtD
Cladribine—Dermatitis—Betamethasone—hematologic cancer	2.78e-06	4.38e-05	CcSEcCtD
Cladribine—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.78e-06	4.37e-05	CcSEcCtD
Cladribine—Fatigue—Methotrexate—hematologic cancer	2.77e-06	4.37e-05	CcSEcCtD
Cladribine—Headache—Betamethasone—hematologic cancer	2.77e-06	4.36e-05	CcSEcCtD
Cladribine—Headache—Dexamethasone—hematologic cancer	2.77e-06	4.36e-05	CcSEcCtD
Cladribine—Infection—Doxorubicin—hematologic cancer	2.77e-06	4.36e-05	CcSEcCtD
Cladribine—Asthenia—Prednisone—hematologic cancer	2.76e-06	4.35e-05	CcSEcCtD
Cladribine—Pain—Methotrexate—hematologic cancer	2.75e-06	4.33e-05	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.74e-06	4.32e-05	CcSEcCtD
Cladribine—Nervous system disorder—Doxorubicin—hematologic cancer	2.73e-06	4.3e-05	CcSEcCtD
Cladribine—Thrombocytopenia—Doxorubicin—hematologic cancer	2.73e-06	4.29e-05	CcSEcCtD
Cladribine—Pruritus—Prednisone—hematologic cancer	2.72e-06	4.29e-05	CcSEcCtD
Cladribine—Insomnia—Epirubicin—hematologic cancer	2.72e-06	4.29e-05	CcSEcCtD
Cladribine—Tachycardia—Doxorubicin—hematologic cancer	2.72e-06	4.28e-05	CcSEcCtD
Cladribine—DCK—Desoximetasone—Betamethasone—hematologic cancer	2.71e-06	0.00237	CbGdCrCtD
Cladribine—DCK—Desoximetasone—Dexamethasone—hematologic cancer	2.71e-06	0.00237	CbGdCrCtD
Cladribine—Skin disorder—Doxorubicin—hematologic cancer	2.71e-06	4.26e-05	CcSEcCtD
Cladribine—Paraesthesia—Epirubicin—hematologic cancer	2.7e-06	4.26e-05	CcSEcCtD
Cladribine—Hyperhidrosis—Doxorubicin—hematologic cancer	2.69e-06	4.24e-05	CcSEcCtD
Cladribine—Dyspnoea—Epirubicin—hematologic cancer	2.68e-06	4.23e-05	CcSEcCtD
Cladribine—Somnolence—Epirubicin—hematologic cancer	2.68e-06	4.21e-05	CcSEcCtD
Cladribine—Anorexia—Doxorubicin—hematologic cancer	2.66e-06	4.18e-05	CcSEcCtD
Cladribine—Feeling abnormal—Methotrexate—hematologic cancer	2.65e-06	4.17e-05	CcSEcCtD
Cladribine—DCK—Desoximetasone—Triamcinolone—hematologic cancer	2.64e-06	0.00231	CbGdCrCtD
Cladribine—Diarrhoea—Prednisone—hematologic cancer	2.63e-06	4.15e-05	CcSEcCtD
Cladribine—Gastrointestinal pain—Methotrexate—hematologic cancer	2.63e-06	4.14e-05	CcSEcCtD
Cladribine—DCK—Diflorasone—Dexamethasone—hematologic cancer	2.63e-06	0.0023	CbGdCrCtD
Cladribine—DCK—Diflorasone—Betamethasone—hematologic cancer	2.63e-06	0.0023	CbGdCrCtD
Cladribine—Nausea—Betamethasone—hematologic cancer	2.63e-06	4.13e-05	CcSEcCtD
Cladribine—Nausea—Dexamethasone—hematologic cancer	2.63e-06	4.13e-05	CcSEcCtD
Cladribine—Decreased appetite—Epirubicin—hematologic cancer	2.62e-06	4.12e-05	CcSEcCtD
Cladribine—Hypotension—Doxorubicin—hematologic cancer	2.6e-06	4.1e-05	CcSEcCtD
Cladribine—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.6e-06	4.09e-05	CcSEcCtD
Cladribine—Fatigue—Epirubicin—hematologic cancer	2.6e-06	4.09e-05	CcSEcCtD
Cladribine—Pain—Epirubicin—hematologic cancer	2.57e-06	4.05e-05	CcSEcCtD
Cladribine—Constipation—Epirubicin—hematologic cancer	2.57e-06	4.05e-05	CcSEcCtD
Cladribine—DCK—Diflorasone—Triamcinolone—hematologic cancer	2.57e-06	0.00225	CbGdCrCtD
Cladribine—Urticaria—Methotrexate—hematologic cancer	2.56e-06	4.02e-05	CcSEcCtD
Cladribine—Dizziness—Prednisone—hematologic cancer	2.55e-06	4.01e-05	CcSEcCtD
Cladribine—Body temperature increased—Methotrexate—hematologic cancer	2.54e-06	4e-05	CcSEcCtD
Cladribine—Abdominal pain—Methotrexate—hematologic cancer	2.54e-06	4e-05	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.54e-06	4e-05	CcSEcCtD
Cladribine—Insomnia—Doxorubicin—hematologic cancer	2.52e-06	3.97e-05	CcSEcCtD
Cladribine—DCK—Desoximetasone—Prednisone—hematologic cancer	2.51e-06	0.0022	CbGdCrCtD
Cladribine—Paraesthesia—Doxorubicin—hematologic cancer	2.5e-06	3.94e-05	CcSEcCtD
Cladribine—Dyspnoea—Doxorubicin—hematologic cancer	2.48e-06	3.91e-05	CcSEcCtD
Cladribine—Feeling abnormal—Epirubicin—hematologic cancer	2.48e-06	3.91e-05	CcSEcCtD
Cladribine—Somnolence—Doxorubicin—hematologic cancer	2.48e-06	3.9e-05	CcSEcCtD
Cladribine—Gastrointestinal pain—Epirubicin—hematologic cancer	2.46e-06	3.88e-05	CcSEcCtD
Cladribine—DCK—Desoximetasone—Prednisolone—hematologic cancer	2.45e-06	0.00214	CbGdCrCtD
Cladribine—Vomiting—Prednisone—hematologic cancer	2.45e-06	3.85e-05	CcSEcCtD
Cladribine—DCK—Diflorasone—Prednisone—hematologic cancer	2.43e-06	0.00213	CbGdCrCtD
Cladribine—Rash—Prednisone—hematologic cancer	2.43e-06	3.82e-05	CcSEcCtD
Cladribine—Dermatitis—Prednisone—hematologic cancer	2.42e-06	3.82e-05	CcSEcCtD
Cladribine—Decreased appetite—Doxorubicin—hematologic cancer	2.42e-06	3.81e-05	CcSEcCtD
Cladribine—Headache—Prednisone—hematologic cancer	2.41e-06	3.8e-05	CcSEcCtD
Cladribine—POLE—Cell Cycle—CCND1—hematologic cancer	2.41e-06	7.08e-05	CbGpPWpGaD
Cladribine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.4e-06	3.79e-05	CcSEcCtD
Cladribine—Fatigue—Doxorubicin—hematologic cancer	2.4e-06	3.78e-05	CcSEcCtD
Cladribine—Urticaria—Epirubicin—hematologic cancer	2.39e-06	3.77e-05	CcSEcCtD
Cladribine—Pain—Doxorubicin—hematologic cancer	2.38e-06	3.75e-05	CcSEcCtD
Cladribine—Constipation—Doxorubicin—hematologic cancer	2.38e-06	3.75e-05	CcSEcCtD
Cladribine—Abdominal pain—Epirubicin—hematologic cancer	2.38e-06	3.75e-05	CcSEcCtD
Cladribine—Body temperature increased—Epirubicin—hematologic cancer	2.38e-06	3.75e-05	CcSEcCtD
Cladribine—DCK—Diflorasone—Prednisolone—hematologic cancer	2.38e-06	0.00208	CbGdCrCtD
Cladribine—SLC22A1—Metabolism—PC—hematologic cancer	2.38e-06	6.98e-05	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—MDM2—hematologic cancer	2.38e-06	6.98e-05	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—AKT1—hematologic cancer	2.37e-06	6.96e-05	CbGpPWpGaD
Cladribine—Hypersensitivity—Methotrexate—hematologic cancer	2.37e-06	3.73e-05	CcSEcCtD
Cladribine—POLE—Cell Cycle—CDKN1A—hematologic cancer	2.33e-06	6.85e-05	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—MAPK3—hematologic cancer	2.32e-06	6.8e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—RB1—hematologic cancer	2.31e-06	6.79e-05	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—EP300—hematologic cancer	2.31e-06	6.79e-05	CbGpPWpGaD
Cladribine—Asthenia—Methotrexate—hematologic cancer	2.31e-06	3.63e-05	CcSEcCtD
Cladribine—RRM2—Metabolism—GSTP1—hematologic cancer	2.3e-06	6.77e-05	CbGpPWpGaD
Cladribine—Feeling abnormal—Doxorubicin—hematologic cancer	2.3e-06	3.61e-05	CcSEcCtD
Cladribine—SLC22A1—Metabolism—GBA—hematologic cancer	2.3e-06	6.74e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SLC35B2—hematologic cancer	2.3e-06	6.74e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—TFRC—hematologic cancer	2.29e-06	6.74e-05	CbGpPWpGaD
Cladribine—Nausea—Prednisone—hematologic cancer	2.29e-06	3.6e-05	CcSEcCtD
Cladribine—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.28e-06	3.59e-05	CcSEcCtD
Cladribine—Pruritus—Methotrexate—hematologic cancer	2.28e-06	3.58e-05	CcSEcCtD
Cladribine—ABCG2—Metabolism—MTAP—hematologic cancer	2.28e-06	6.69e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	2.27e-06	6.68e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—MTHFR—hematologic cancer	2.27e-06	6.68e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—MTAP—hematologic cancer	2.25e-06	6.62e-05	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—MYC—hematologic cancer	2.25e-06	6.62e-05	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—MAPK3—hematologic cancer	2.22e-06	6.53e-05	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—EP300—hematologic cancer	2.22e-06	6.52e-05	CbGpPWpGaD
Cladribine—Hypersensitivity—Epirubicin—hematologic cancer	2.22e-06	3.49e-05	CcSEcCtD
Cladribine—SLC22A1—Transmission across Chemical Synapses—MDM2—hematologic cancer	2.21e-06	6.5e-05	CbGpPWpGaD
Cladribine—Urticaria—Doxorubicin—hematologic cancer	2.21e-06	3.48e-05	CcSEcCtD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	2.21e-06	6.48e-05	CbGpPWpGaD
Cladribine—Body temperature increased—Doxorubicin—hematologic cancer	2.2e-06	3.47e-05	CcSEcCtD
Cladribine—Abdominal pain—Doxorubicin—hematologic cancer	2.2e-06	3.47e-05	CcSEcCtD
Cladribine—PNP—Metabolism—PTEN—hematologic cancer	2.2e-06	6.47e-05	CbGpPWpGaD
Cladribine—Diarrhoea—Methotrexate—hematologic cancer	2.2e-06	3.47e-05	CcSEcCtD
Cladribine—SLC22A2—Neuronal System—CREB1—hematologic cancer	2.2e-06	6.46e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—ABCB1—hematologic cancer	2.18e-06	6.41e-05	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—BRAF—hematologic cancer	2.17e-06	6.38e-05	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—MYC—hematologic cancer	2.16e-06	6.35e-05	CbGpPWpGaD
Cladribine—Asthenia—Epirubicin—hematologic cancer	2.16e-06	3.4e-05	CcSEcCtD
Cladribine—DCK—Metabolism—GSTP1—hematologic cancer	2.15e-06	6.33e-05	CbGpPWpGaD
Cladribine—Pruritus—Epirubicin—hematologic cancer	2.13e-06	3.35e-05	CcSEcCtD
Cladribine—Dizziness—Methotrexate—hematologic cancer	2.13e-06	3.35e-05	CcSEcCtD
Cladribine—SLC22A2—SLC-mediated transmembrane transport—ALB—hematologic cancer	2.12e-06	6.23e-05	CbGpPWpGaD
Cladribine—POLA1—Mitotic M-M/G1 phases—MAPK3—hematologic cancer	2.12e-06	6.22e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—NCOR1—hematologic cancer	2.12e-06	6.22e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—GSTM1—hematologic cancer	2.12e-06	6.22e-05	CbGpPWpGaD
Cladribine—PNP—Metabolism—EP300—hematologic cancer	2.1e-06	6.17e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—MTAP—hematologic cancer	2.1e-06	6.17e-05	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—CYCS—hematologic cancer	2.09e-06	6.13e-05	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—MAPK3—hematologic cancer	2.07e-06	6.08e-05	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—CYCS—hematologic cancer	2.07e-06	6.07e-05	CbGpPWpGaD
Cladribine—Diarrhoea—Epirubicin—hematologic cancer	2.06e-06	3.24e-05	CcSEcCtD
Cladribine—Hypersensitivity—Doxorubicin—hematologic cancer	2.05e-06	3.23e-05	CcSEcCtD
Cladribine—SLC22A1—Neuronal System—CREB1—hematologic cancer	2.05e-06	6.02e-05	CbGpPWpGaD
Cladribine—Vomiting—Methotrexate—hematologic cancer	2.05e-06	3.22e-05	CcSEcCtD
Cladribine—DCK—Metabolism—ABCB1—hematologic cancer	2.04e-06	5.99e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDKN2A—hematologic cancer	2.03e-06	5.97e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—FHL2—hematologic cancer	2.03e-06	5.96e-05	CbGpPWpGaD
Cladribine—Rash—Methotrexate—hematologic cancer	2.03e-06	3.19e-05	CcSEcCtD
Cladribine—Dermatitis—Methotrexate—hematologic cancer	2.03e-06	3.19e-05	CcSEcCtD
Cladribine—SLC22A1—Neuronal System—BRAF—hematologic cancer	2.02e-06	5.95e-05	CbGpPWpGaD
Cladribine—Headache—Methotrexate—hematologic cancer	2.02e-06	3.17e-05	CcSEcCtD
Cladribine—RRM2—Cell Cycle—MYC—hematologic cancer	2.01e-06	5.92e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	2.01e-06	5.91e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—FHL2—hematologic cancer	2.01e-06	5.9e-05	CbGpPWpGaD
Cladribine—Asthenia—Doxorubicin—hematologic cancer	2e-06	3.15e-05	CcSEcCtD
Cladribine—Dizziness—Epirubicin—hematologic cancer	1.99e-06	3.14e-05	CcSEcCtD
Cladribine—ABCG2—Metabolism—AGRN—hematologic cancer	1.99e-06	5.84e-05	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—MAPK3—hematologic cancer	1.99e-06	5.84e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—GSTM1—hematologic cancer	1.98e-06	5.81e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—NCOR1—hematologic cancer	1.98e-06	5.81e-05	CbGpPWpGaD
Cladribine—SLC22A1—SLC-mediated transmembrane transport—ALB—hematologic cancer	1.98e-06	5.81e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—MDM2—hematologic cancer	1.97e-06	5.79e-05	CbGpPWpGaD
Cladribine—Pruritus—Doxorubicin—hematologic cancer	1.97e-06	3.1e-05	CcSEcCtD
Cladribine—SLC22A2—Metabolism—AGRN—hematologic cancer	1.97e-06	5.78e-05	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—MYC—hematologic cancer	1.93e-06	5.68e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.93e-06	5.66e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CCND1—hematologic cancer	1.92e-06	5.64e-05	CbGpPWpGaD
Cladribine—Vomiting—Epirubicin—hematologic cancer	1.91e-06	3.01e-05	CcSEcCtD
Cladribine—Nausea—Methotrexate—hematologic cancer	1.91e-06	3.01e-05	CcSEcCtD
Cladribine—RRM1—Metabolism—PIK3CG—hematologic cancer	1.91e-06	5.61e-05	CbGpPWpGaD
Cladribine—Diarrhoea—Doxorubicin—hematologic cancer	1.91e-06	3e-05	CcSEcCtD
Cladribine—Rash—Epirubicin—hematologic cancer	1.9e-06	2.99e-05	CcSEcCtD
Cladribine—Dermatitis—Epirubicin—hematologic cancer	1.9e-06	2.99e-05	CcSEcCtD
Cladribine—Headache—Epirubicin—hematologic cancer	1.89e-06	2.97e-05	CcSEcCtD
Cladribine—ABCG2—Metabolism—HMMR—hematologic cancer	1.89e-06	5.54e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—IDH2—hematologic cancer	1.89e-06	5.54e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—MTHFR—hematologic cancer	1.87e-06	5.5e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—FHL2—hematologic cancer	1.87e-06	5.5e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—IDH2—hematologic cancer	1.87e-06	5.48e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—HMMR—hematologic cancer	1.87e-06	5.48e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	1.86e-06	5.46e-05	CbGpPWpGaD
Cladribine—Dizziness—Doxorubicin—hematologic cancer	1.84e-06	2.9e-05	CcSEcCtD
Cladribine—SLC22A1—Metabolism—AGRN—hematologic cancer	1.83e-06	5.39e-05	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—MDM2—hematologic cancer	1.82e-06	5.35e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDKN1B—hematologic cancer	1.8e-06	5.29e-05	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—MAPK3—hematologic cancer	1.8e-06	5.28e-05	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PIK3CA—hematologic cancer	1.79e-06	5.26e-05	CbGpPWpGaD
Cladribine—Nausea—Epirubicin—hematologic cancer	1.79e-06	2.82e-05	CcSEcCtD
Cladribine—ABCG2—Metabolism—ARNTL—hematologic cancer	1.77e-06	5.21e-05	CbGpPWpGaD
Cladribine—Vomiting—Doxorubicin—hematologic cancer	1.77e-06	2.79e-05	CcSEcCtD
Cladribine—RRM1—Metabolism—CREBBP—hematologic cancer	1.77e-06	5.2e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—EP300—hematologic cancer	1.77e-06	5.19e-05	CbGpPWpGaD
Cladribine—Rash—Doxorubicin—hematologic cancer	1.76e-06	2.77e-05	CcSEcCtD
Cladribine—Dermatitis—Doxorubicin—hematologic cancer	1.75e-06	2.76e-05	CcSEcCtD
Cladribine—SLC22A2—Metabolism—ARNTL—hematologic cancer	1.75e-06	5.16e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—MTHFR—hematologic cancer	1.75e-06	5.14e-05	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—MYC—hematologic cancer	1.75e-06	5.14e-05	CbGpPWpGaD
Cladribine—Headache—Doxorubicin—hematologic cancer	1.74e-06	2.75e-05	CcSEcCtD
Cladribine—ABCG2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.74e-06	5.12e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—HMMR—hematologic cancer	1.74e-06	5.11e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—IDH2—hematologic cancer	1.74e-06	5.11e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CA9—hematologic cancer	1.72e-06	5.07e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ACP5—hematologic cancer	1.72e-06	5.07e-05	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.72e-06	5.06e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CCND1—hematologic cancer	1.72e-06	5.05e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ACP5—hematologic cancer	1.71e-06	5.01e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CA9—hematologic cancer	1.71e-06	5.01e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NCOR2—hematologic cancer	1.7e-06	5e-05	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—MDM2—hematologic cancer	1.7e-06	4.98e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NCOR2—hematologic cancer	1.68e-06	4.95e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PIK3CD—hematologic cancer	1.68e-06	4.93e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDKN1A—hematologic cancer	1.66e-06	4.88e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—ALB—hematologic cancer	1.66e-06	4.87e-05	CbGpPWpGaD
Cladribine—Nausea—Doxorubicin—hematologic cancer	1.65e-06	2.61e-05	CcSEcCtD
Cladribine—RRM2—Cell Cycle—TP53—hematologic cancer	1.65e-06	4.86e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ARNTL—hematologic cancer	1.64e-06	4.81e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—IDH1—hematologic cancer	1.62e-06	4.76e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.61e-06	4.72e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—IDH1—hematologic cancer	1.6e-06	4.72e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ABCC3—hematologic cancer	1.6e-06	4.71e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—TXN—hematologic cancer	1.6e-06	4.71e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GSTO1—hematologic cancer	1.6e-06	4.71e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CA9—hematologic cancer	1.59e-06	4.67e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ACP5—hematologic cancer	1.59e-06	4.67e-05	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—TP53—hematologic cancer	1.59e-06	4.66e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GSTO1—hematologic cancer	1.59e-06	4.66e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ABCC3—hematologic cancer	1.59e-06	4.66e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—TXN—hematologic cancer	1.59e-06	4.66e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PIK3R1—hematologic cancer	1.58e-06	4.66e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—MAPK3—hematologic cancer	1.58e-06	4.65e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—EP300—hematologic cancer	1.58e-06	4.64e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PIK3CG—hematologic cancer	1.57e-06	4.62e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NCOR2—hematologic cancer	1.57e-06	4.61e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SPHK1—hematologic cancer	1.57e-06	4.61e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SPHK1—hematologic cancer	1.55e-06	4.56e-05	CbGpPWpGaD
Cladribine—PNP—Metabolism—PIK3CA—hematologic cancer	1.55e-06	4.56e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—MYC—hematologic cancer	1.54e-06	4.53e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—UGT1A1—hematologic cancer	1.51e-06	4.43e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—IDH1—hematologic cancer	1.5e-06	4.39e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—UGT1A1—hematologic cancer	1.49e-06	4.38e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ABCC3—hematologic cancer	1.48e-06	4.35e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GSTO1—hematologic cancer	1.48e-06	4.35e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—TXN—hematologic cancer	1.48e-06	4.35e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PIK3CG—hematologic cancer	1.47e-06	4.32e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CRABP1—hematologic cancer	1.47e-06	4.31e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SLC22A1—hematologic cancer	1.47e-06	4.31e-05	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—AKT1—hematologic cancer	1.46e-06	4.3e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PIK3CB—hematologic cancer	1.46e-06	4.3e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CREBBP—hematologic cancer	1.46e-06	4.28e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SLC22A1—hematologic cancer	1.45e-06	4.26e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CRABP1—hematologic cancer	1.45e-06	4.26e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SPHK1—hematologic cancer	1.45e-06	4.25e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ALOX5—hematologic cancer	1.43e-06	4.2e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—MAPK3—hematologic cancer	1.42e-06	4.16e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ALOX5—hematologic cancer	1.41e-06	4.16e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—UGT1A1—hematologic cancer	1.39e-06	4.09e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NUP98—hematologic cancer	1.38e-06	4.07e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PIK3CD—hematologic cancer	1.38e-06	4.06e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—MYC—hematologic cancer	1.38e-06	4.05e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NUP98—hematologic cancer	1.37e-06	4.02e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—ALB—hematologic cancer	1.36e-06	4.01e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—CREBBP—hematologic cancer	1.36e-06	4e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CRABP1—hematologic cancer	1.35e-06	3.97e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ADCY7—hematologic cancer	1.34e-06	3.95e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NCOA3—hematologic cancer	1.34e-06	3.95e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NUP214—hematologic cancer	1.33e-06	3.92e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ADCY7—hematologic cancer	1.33e-06	3.91e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NCOA3—hematologic cancer	1.33e-06	3.91e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NUP214—hematologic cancer	1.32e-06	3.88e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ALOX5—hematologic cancer	1.32e-06	3.87e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—MTR—hematologic cancer	1.31e-06	3.84e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PIK3R1—hematologic cancer	1.31e-06	3.83e-05	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.3e-06	3.83e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ABCG2—hematologic cancer	1.29e-06	3.8e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—MTR—hematologic cancer	1.29e-06	3.8e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PIK3CD—hematologic cancer	1.29e-06	3.8e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ENO2—hematologic cancer	1.28e-06	3.77e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NUP98—hematologic cancer	1.28e-06	3.75e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—ALB—hematologic cancer	1.28e-06	3.75e-05	CbGpPWpGaD
Cladribine—PNP—Metabolism—AKT1—hematologic cancer	1.27e-06	3.73e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ENO2—hematologic cancer	1.27e-06	3.73e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PTEN—hematologic cancer	1.26e-06	3.71e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GSTT1—hematologic cancer	1.24e-06	3.65e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NCOA3—hematologic cancer	1.24e-06	3.64e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ADCY7—hematologic cancer	1.24e-06	3.64e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NUP214—hematologic cancer	1.23e-06	3.62e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GSTT1—hematologic cancer	1.23e-06	3.62e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PIK3R1—hematologic cancer	1.22e-06	3.58e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SDC1—hematologic cancer	1.22e-06	3.57e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.21e-06	3.57e-05	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—AKT1—hematologic cancer	1.21e-06	3.56e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ABCG2—hematologic cancer	1.21e-06	3.54e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—MTR—hematologic cancer	1.21e-06	3.54e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—EP300—hematologic cancer	1.21e-06	3.54e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PIK3CB—hematologic cancer	1.2e-06	3.54e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SDC1—hematologic cancer	1.2e-06	3.53e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ENO2—hematologic cancer	1.18e-06	3.47e-05	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.16e-06	3.42e-05	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.15e-06	3.38e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GSTT1—hematologic cancer	1.15e-06	3.37e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—TP53—hematologic cancer	1.13e-06	3.32e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PIK3CB—hematologic cancer	1.13e-06	3.31e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SDC1—hematologic cancer	1.12e-06	3.29e-05	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.09e-06	3.2e-05	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.08e-06	3.17e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.07e-06	3.15e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PTEN—hematologic cancer	1.04e-06	3.06e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CD44—hematologic cancer	1.03e-06	3.04e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NQO1—hematologic cancer	1.03e-06	3.04e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CD44—hematologic cancer	1.02e-06	3e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NQO1—hematologic cancer	1.02e-06	3e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—ALB—hematologic cancer	1e-06	2.95e-05	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—HRAS—hematologic cancer	9.99e-07	2.93e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—EP300—hematologic cancer	9.93e-07	2.92e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYCS—hematologic cancer	9.78e-07	2.87e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PTEN—hematologic cancer	9.73e-07	2.86e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—HSP90AA1—hematologic cancer	9.71e-07	2.85e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYCS—hematologic cancer	9.68e-07	2.84e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—HSP90AA1—hematologic cancer	9.61e-07	2.82e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NQO1—hematologic cancer	9.53e-07	2.8e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CD44—hematologic cancer	9.53e-07	2.8e-05	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—HRAS—hematologic cancer	9.31e-07	2.73e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—EP300—hematologic cancer	9.28e-07	2.73e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYCS—hematologic cancer	9.02e-07	2.65e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—HSP90AA1—hematologic cancer	8.96e-07	2.63e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PIK3CA—hematologic cancer	8.92e-07	2.62e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GSTP1—hematologic cancer	8.62e-07	2.53e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GSTP1—hematologic cancer	8.53e-07	2.51e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ABCB1—hematologic cancer	8.16e-07	2.4e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ABCB1—hematologic cancer	8.07e-07	2.37e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GSTP1—hematologic cancer	7.95e-07	2.34e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NCOR1—hematologic cancer	7.92e-07	2.33e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GSTM1—hematologic cancer	7.92e-07	2.33e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NCOR1—hematologic cancer	7.84e-07	2.3e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GSTM1—hematologic cancer	7.84e-07	2.3e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ABCB1—hematologic cancer	7.52e-07	2.21e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PIK3CA—hematologic cancer	7.34e-07	2.16e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NCOR1—hematologic cancer	7.3e-07	2.15e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GSTM1—hematologic cancer	7.3e-07	2.15e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—AKT1—hematologic cancer	7.29e-07	2.14e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—MTHFR—hematologic cancer	7e-07	2.06e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—MTHFR—hematologic cancer	6.93e-07	2.04e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PIK3CA—hematologic cancer	6.86e-07	2.02e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—MTHFR—hematologic cancer	6.46e-07	1.9e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—AKT1—hematologic cancer	6e-07	1.76e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PIK3CG—hematologic cancer	5.88e-07	1.73e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PIK3CG—hematologic cancer	5.82e-07	1.71e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—AKT1—hematologic cancer	5.61e-07	1.65e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CREBBP—hematologic cancer	5.45e-07	1.6e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PIK3CG—hematologic cancer	5.42e-07	1.59e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CREBBP—hematologic cancer	5.4e-07	1.59e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PIK3CD—hematologic cancer	5.17e-07	1.52e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PIK3CD—hematologic cancer	5.12e-07	1.5e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ALB—hematologic cancer	5.1e-07	1.5e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ALB—hematologic cancer	5.05e-07	1.48e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CREBBP—hematologic cancer	5.03e-07	1.48e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PIK3R1—hematologic cancer	4.88e-07	1.43e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PIK3R1—hematologic cancer	4.83e-07	1.42e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PIK3CD—hematologic cancer	4.77e-07	1.4e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ALB—hematologic cancer	4.71e-07	1.38e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PIK3CB—hematologic cancer	4.51e-07	1.32e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PIK3R1—hematologic cancer	4.5e-07	1.32e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PIK3CB—hematologic cancer	4.46e-07	1.31e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PIK3CB—hematologic cancer	4.16e-07	1.22e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PTEN—hematologic cancer	3.89e-07	1.14e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PTEN—hematologic cancer	3.85e-07	1.13e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—EP300—hematologic cancer	3.71e-07	1.09e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—EP300—hematologic cancer	3.67e-07	1.08e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PTEN—hematologic cancer	3.59e-07	1.06e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—EP300—hematologic cancer	3.42e-07	1.01e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PIK3CA—hematologic cancer	2.75e-07	8.07e-06	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PIK3CA—hematologic cancer	2.72e-07	7.99e-06	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PIK3CA—hematologic cancer	2.53e-07	7.44e-06	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—AKT1—hematologic cancer	2.24e-07	6.59e-06	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—AKT1—hematologic cancer	2.22e-07	6.52e-06	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—AKT1—hematologic cancer	2.07e-07	6.08e-06	CbGpPWpGaD
